AMRX FY 2021 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMRXAmneal Pharmaceuticals, Inc.

$4B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.1B+5.1% YoY

Gross Profit

$769M36.7% margin

Operating Income

$153M7.3% margin

Net Income

$11M0.5% margin

EPS (Diluted)

$0.07

Cash Flow

Operating Cash Flow

$242M

Free Cash Flow

$194M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.9B

Total Liabilities

$3.6B

Stockholders' Equity

$360M

Cash & Equivalents

$248M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.1B	$2.0B	+5.1%
Gross Profit	$769M	$628M	+22.4%
Operating Income	$153M	$91M	+67.5%
Net Income	$11M	$91M	-88.3%